Cytotoxic activity of acyl phloroglucinols isolated from the leaves of Eucalyptus cinerea F. Muell. ex Benth. cultivated in Egypt

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Soliman, Fathy M ^a   Fathy, Magda M ^a   Salama, Maha M ^a   Al Abd, Ahmed M ^a,b   Saber, Fatema R ^a   El Halawany, Ali M ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PHLOROGLUCINOL; PLANT EXTRACT;

ACYLATION; ANALOGS AND DERIVATIVES; CELL SURVIVAL; CHEMISTRY; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; EGYPT; EUCALYPTUS; HUMAN; ISOLATION AND PURIFICATION; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PLANT LEAF; SPECIES DIFFERENCE; TREATMENT OUTCOME; TUMOR CELL LINE;

ACYLATION; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EGYPT; EUCALYPTUS; HUMANS; NEOPLASMS, EXPERIMENTAL; PHLOROGLUCINOL; PLANT EXTRACTS; PLANT LEAVES; SPECIES SPECIFICITY; TREATMENT OUTCOME;

EID: 84903789643     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05410     Document Type: Article

References (26)

1. Chan, M. Cancer in developing countries: facing the challenge, WHO, (2010): 21/ 09/2010, IAEA forum: http://www.who.int/dg/speeches/2010/iaea-forum- 20100921/en/index.html.
2. Ginsburg, O. M. Breast and cervical cancer control in low and middle-income countries: Human rights meet sound health policy. Journal of Cancer Policy. 1, e35-e41 (2013).
3. Siegel, R. et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 62, 220-241 (2012).
4. Saslow, D. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer J. Clin. 62, 147-172 (2012).
5. Elattar, I. A., Hassan, N.M., Lamee, M. M. & Elbasmy, A. A. Cancer profile at the national Cancer Institute, Egypt, 2002-2003. J. Clin. Onc. 23, 54-57 (2005).
6. Omar, S. et al. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr. Health J. 9, 448-63 (2003). (Pubitemid 40521212)
7. Verma, S. & Singh, S. Current and future status of herbal medicine. Vet. World. 1, 347-350 (2008).
8. Lee, K. H., Haung, E. S., Piantadosi, C., Pagano, J. S. & Geissman, T. A. Cytotoxicity of sesquiterpene lactones. Cancer Res. 31, 1649-1654 (1971).
9. Nagpal, N., Shah, G., Arora, M. N., Shri, R. & Arya, A. Phytochemical and Pharmacological aspects of Eucalyptus genus. IJPSR. 12, 28-36 (2010).
10. Islam, F., Khatun, H.,Ghosh, S., Ali, M. M.&Khanam, J.A. Bioassay of Eucalyptus extracts for anti cancer activity against Ehrlich ascites carcinoma(eac) cells in Swiss albino mice. Asian Pac. J. Trop. Biomed. 2, 394-398 (2012).
11. Ghisalberti, E. L. Bioactive acylphloroglucinol derivatives from Eucalyptus species. Phytochem. 41, 7-22 (1996).
12. Singh, I. P. & Etoh, H. Biological activities of phloroglucinol derivatives from Eucalyptus species. Nat. Prod. Sci. 3, 1-7 (1997). (Pubitemid 27362013)
13. Sidana, J. et al. Antibacterial sideroxylonals and loxophlebal A from Eucalyptus loxophleba foliage. Fitoter. 81, 878-883(2010).
14. Sidana, J., Singh, S., Arora, S. K., Foley, W. J. & Singh, I. P. Formylated phloroglucinols from Eucalyptus loxophleba foliage. Fitoter. 82, 1118-1122 (2011).
15. Takasaki, M., Konoshima, T., Kozuka, M. & Tokuda, H. Anti-tumor-promoting activities of euglobals from Eucalyptus plants. Biol Pharm Bull. 18, 435-8 (1995).
16. Zhou et al. Effect of Eucalyptus globulus oil on activation of nuclearfactor- Kappa B in THP- 1 cells. Zeinang Da Xue Xue Boa Yi Xue Ban. 32, 315-318 (2003).
17. Bailey, L. H. Manual of Cultivated Plants 3rd ed.(The Macmillan Company, New York, 1958).
18. Skehan, P. et al. New Colourimetric Cytotoxicity Assay for Anti-Cancer Drug Screening. J. Nat. Canc. inst. 82, 1107-1112 (1990). (Pubitemid 20213250)
19. Amano, T., Komiya, T., Hori, M. & Goto, M. Isolation and characterization of euglobals from Eucalyptus globulus Labill. by preparative reversed-phase liquid chromatography. J. of Chroma. 208, 347-355 (1981).
20. Satoh, H. et al. Structures of sideroxylonals from Eucalyptus sideroxylon. Chem. Lett. 10, 1917-1920 (1992).
21. Murata, M. et al. Macrocarpal A, a Novel Antibacterial Compound from Eucalyptus macrocarpa. Agric. Biol. Chem. 54, 3221-3226 (1990).
22. Peng, L. et al. Euglobal-IIIa, a novel acylphloroglucinol-sesquiterpene derivative from Eucalyptus robusta: absolute structure and cytotoxicity. Nat. Prod. Bioprospect. 1, 101-103 (2011).
23. Mangusan, D. The World Health Organization's Fight against Cancer: Strategies That Prevent, Cure and Care. World Health Organization (WHO) Media Centre (Fact Sheet No. 297, http://www.who.int/mediacentre/factsheets/fs297/en/ index. html (Accessed on 19/10/2009).
24. Mann, J. Natural products in cancer chemotherapy: past, present and future. Nat. Rev. Cancer. 2, 143-8 (2002). (Pubitemid 37328801)
25. Boyd, M. R. The NCI in vitro anticancer drug discovery screen. Concept, implementation, and operation, 1985-1995. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. [Teicher, B. A. (ed), Humana Press, Totowa, NJ, 23-42 1997).
26. Takasaki, M. et al. Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis. Cancer Lett. 155, 61-5 (2000). (Pubitemid 30256225)